CANCER OF THE BREAST. This item is unavailable.CANCER OF THE BREAST

• Offers a comprehensive summary of breast cancer initiation and progression
• Explores risk factors and advances in the reduction of breast cancer risks
• Includes coverage of genetic counselling and methods of self-screening for breast cancer
• Covers future perspective in breast cancer diagnostic tools and treatment strategies

Dr. Kashyap is currently at the Brown Center for Immunotherapy, Indiana University, working on identifying novel biomarkers for designing and modifying immunotherapy approaches for breast cancer targeting TME components. He received his PhD in molecular biology on the main subject of tumor microenvironment in breast cancer from PGIMER, Chandigarh, India, and holds an MSc in Human Genomics. He published 70 articles and five book chapters. He is also a reviewer and editorial board member of many PubMed/Scopus-indexed journals. His h-index is 26, and FWCI is 2.91

Dr. Sharma is an early career scientist in biological science at the School of Medicine, Indiana University Indianapolis, USA, working on Multiple Myeloma genomics characterizations. She holds an MSc in Microbial Biotechnology and has good publications in peer-reviewed international journals.

Dr. Garg is currently an Associate Professor at Chandigarh University in India. In 2018, he earned his PhD in Neurology and holds his M.Sc. in Medical Biochemistry. He has published 47 articles in prestigious journals and 12 book chapters. He is also a reviewer and editorial board member of 12 PubMed/Scopus-indexed journals.

Dr. Salman is Director of the Brown Center for Immunotherapy, Co-leader of the HHM CC Program, Don Brown Professor of Immunotherapy, and Professor of the Department of Medicine, Microbiology and Immunology, Indiana University, Indianapolis, IN 46202. She holds the MD and PhD in Medicine. She is on the editorial board of several journals with a high impact factor. She is mentioned as America’s most honored doctor (2020-2022). She has published several articles. Her expertise is in the engineering and manufacturing Chimeric Antigen Receptor T-cells (CAR-T cells) for treating hematological malignancies and solid tumors.